Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05642026 · ClinicalTrials.gov registry record · Phase 4
INTERCOSTAL NERVE BLOCK: Efficacy of CINB for Patients With Multiple Rib Fractures
A Phase 4 study of Rib Fractures, sponsored by Zachary Warriner.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT05642026: Recruiting Phase 4 study of Rib Fractures, sponsored by Zachary Warriner.
NCT05642026 is a Phase 4 study of Rib Fractures that is actively recruiting participants, run by Zachary Warriner. The registered enrollment target is 180 participants, above the 81-participant average among 9 other Rib Fractures trials with a reported enrollment target (122% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05642026, a Phase 4 study of Rib Fractures, is actively recruiting participants, sponsored by Zachary Warriner.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, randomized, non-blinded study comparing CINB plus medical therapy versus standard medical care (non-steroidals and opioids intravenous/oral inpatient and oral outpatient) alone for patients with multiple rib fractures. The objective of this study is to analyze the effect of continuous intercostal nerve block (CINB) in the treatment of patients admitted to the adult trauma service with rib fractures. The effectiveness of CINB as adjunctive treatment will be compared to standard medical therapy involving nonsteroidal and intravenous/oral opioid medications.
Primary Outcome
time from randomization until the time of discharge
Conditions Studied
Interventions
- DRUG Ropivacaine
- DRUG Non steroidal anti-inflammatory drug and opioids
Study Locations (1)
Kentucky
- University of Kentucky Medical Center - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2025-09-23 |
| Est. Completion | 2027-02-01 |
| Phase | Phase 4 |
What NCT05642026 shows while recruiting
NCT05642026 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, above the 81-participant average among 9 other Rib Fractures trials with a reported enrollment target (122% higher).
The record links to 1 condition, with Rib Fractures appearing as the primary indexed condition, and to 2 interventions - of which Ropivacaine is the first listed.
NCT05642026 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT05642026 about?
NCT05642026 is a clinical study titled "INTERCOSTAL NERVE BLOCK: Efficacy of CINB for Patients With Multiple Rib Fractures". This is a prospective, randomized, non-blinded study comparing CINB plus medical therapy versus standard medical care (non-steroidals and opioids intravenous/oral inpatient and oral outpatient) alone for patients with multiple rib fractures. The objective of this study is to analyze the effect of co...
What is the current status of trial NCT05642026?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 180 participants. The study started on 2025-09-23. Estimated completion is 2027-02-01.
What conditions does trial NCT05642026 study?
This clinical trial studies the following conditions: Rib Fractures.
What interventions are being tested in trial NCT05642026?
The interventions under investigation include: Ropivacaine (DRUG), Non steroidal anti-inflammatory drug and opioids (DRUG).
Who is sponsoring clinical trial NCT05642026?
This trial is sponsored by Zachary Warriner, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05642026 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rib Fractures
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05642026's enrollment target sits among peer trials
180 2nd of 9 the highest of 9 other Rib Fractures trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rib Fractures trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cryo Rib Fracture Study
RECRUITING · Phase 4
-
Analgesic Techniques for Rib Fractures
ACTIVE NOT RECRUITING · Phase 4
-
Ketamine vs Lidocaine in Traumatic Rib Fractures
ACTIVE NOT RECRUITING · Phase 4
-
Ketamine Infusion Therapy for the Management of Acute Pain in Adult Rib Fracture Patients
COMPLETED · Phase 4
-
Trial of Injected Liposomal Bupivacaine vs Bupivacaine Infusion After Surgical Stabilization of Rib Fractures
COMPLETED · Phase 4
-
Blue Light as an Anti-inflammatory and Analgesic Strategy in Thoracic Trauma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI